KARABELAS ARGERIS N
SEC insider (Form 3/4/5 filer). CIK 0001191229. Director at REGENXBIO Inc. (RGNX). 7 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in ROCKVILLE, MD.
Companies KARABELAS ARGERIS N has filed insider reports for
- REGENXBIO Inc. (RGNX): Director
KARABELAS ARGERIS N
CIK: 0001191229
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (42.9%)
Position reduction
Option Exercises (M)2 (28.6%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGNX
REGENXBIO Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 29, 2026RGNX
REGENXBIO Inc.
AwardDirect9.8K shares- - May 30, 2025RGNX
REGENXBIO Inc.
AwardDirect7.8K shares- - Oct 1, 2024RGNX
REGENXBIO Inc.
ExerciseDirect10K shares at avg. $3.76$38K - Oct 1, 2024RGNX
REGENXBIO Inc.
SaleDirect10K shares at avg. $10.11$101K - Sep 3, 2024RGNX
REGENXBIO Inc.
SaleDirect9.3K shares at avg. $11.50$107K - Sep 3, 2024RGNX
REGENXBIO Inc.
ExerciseDirect10K shares at avg. $3.76$38K - Sep 3, 2024RGNX
REGENXBIO Inc.
SaleDirect700 shares at avg. $12.34$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | RGNX REGENXBIO Inc. | Award | 9,807 | - | $0 | Direct |
| May 30, 2025 | RGNX REGENXBIO Inc. | Award | 7,768 | - | - | Direct |
| Oct 1, 2024 | RGNX REGENXBIO Inc. | Exercise | 10,000 | $3.76 | $37,600 | Direct |
| Oct 1, 2024 | RGNX REGENXBIO Inc. | Sale | 10,000 | $10.11 | $101,052 | Direct |
| Sep 3, 2024 | RGNX REGENXBIO Inc. | Sale | 9,300 | $11.50 | $106,950 | Direct |
| Sep 3, 2024 | RGNX REGENXBIO Inc. | Exercise | 10,000 | $3.76 | $37,600 | Direct |
| Sep 3, 2024 | RGNX REGENXBIO Inc. | Sale | 700 | $12.34 | $8,638 | Direct |
1-7 of 7 transactions